You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
南新制藥(688189.SH):正在全力推動、加速帕拉米韋吸入溶液項目的研發工作
格隆匯 12-13 16:04

格隆匯12月13日丨南新制藥(688189.SH)在投資者互動平台表示,公司可用於流感防治的藥物包括力緯(帕拉米韋氯化鈉注射液)、南新牌(磷酸奧司他韋幹混懸劑),其中力緯(帕拉米韋氯化鈉注射液)全年齡段均可用藥,南新牌(磷酸奧司他韋幹混懸劑)除治療作用外還可用於1歲及以上年齡人羣的甲型和乙型流感的預防。流感、合胞、支原體三者感染引起的疾病共同的症狀為發熱、喉嚨痛等,公司產品保施泰(複方布洛芬片)可用於上呼吸道感染引起的發熱症狀治療、耳鼻咽部炎症引起的疼痛。目前公司正在全力推動、加速帕拉米韋吸入溶液項目的研發工作,力爭儘快獲批上市,為抗擊流感病毒發揮良好作用。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account